These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38383758)

  • 1. The synergic and addictive activity of biogenic silver nanoparticle associated with meropenem against carbapenem-resistant Acinetobacter baumannii.
    Allend SO; Oliveira Garcia M; da Cunha KF; de Albernaz DTF; Panagio LA; Nakazaro G; Reis GF; Oliveira TL; Neto ACPS; Hartwig DD
    J Appl Microbiol; 2024 Mar; 135(3):. PubMed ID: 38383758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biogenic silver nanoparticle (Bio-AgNP) has an antibacterial effect against carbapenem-resistant Acinetobacter baumannii with synergism and additivity when combined with polymyxin B.
    Allend SO; Garcia MO; da Cunha KF; de Albernaz DTF; da Silva ME; Ishikame RY; Panagio LA; Nakazaro G; Reis GF; Pereira DB; Hartwig DD
    J Appl Microbiol; 2022 Feb; 132(2):1036-1047. PubMed ID: 34496109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro.
    Güran M; Çakıral K; Teralı K; Kandemir T; Şanlıtürk G; Öcal MM; Nagiyev T; Köksal F
    Pathog Dis; 2023 Jan; 81():. PubMed ID: 37120729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.
    Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E
    Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii.
    Mohd Sazlly Lim S; Heffernan AJ; Zowawi HM; Roberts JA; Sime FB
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1943-1952. PubMed ID: 33884516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii.
    Wang Y; Li X; Wang D; Sun S; Lu C
    Lett Appl Microbiol; 2020 Mar; 70(3):189-195. PubMed ID: 31808159
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Alharbe R; Almansour A; Kwon DH
    Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
    Ni W; Wang Y; Ma X; He Y; Zhao J; Guan J; Li Y; Gao Z
    Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1451-1457. PubMed ID: 36201141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
    Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an
    Beganovic M; Daffinee KE; Luther MK; LaPlante KL
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318006
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Lee S; Razqan GS; Kwon DH
    Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic Analysis of Meropenem and Fosfomycin Combination Against Carbapenem-Resistant
    Mohd Sazlly Lim S; Heffernan AJ; Roberts JA; Sime FB
    Microb Drug Resist; 2021 Apr; 27(4):546-552. PubMed ID: 32898467
    [No Abstract]   [Full Text] [Related]  

  • 16. A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
    Chaiben V; Yamada CH; Telles JP; de Andrade AP; Arend LNVS; Ribeiro VST; Dantas LR; Suss PH; Tuon FF
    J Antimicrob Chemother; 2022 May; 77(6):1676-1684. PubMed ID: 35368079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.
    Mohd Sazlly Lim S; Naicker S; Ayfan AK; Zowawi H; Roberts JA; Sime FB
    Int J Antimicrob Agents; 2020 Oct; 56(4):106115. PubMed ID: 32721600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii.
    Ju YG; Lee HJ; Yim HS; Lee MG; Sohn JW; Yoon YK
    Sci Rep; 2022 May; 12(1):7541. PubMed ID: 35534512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Antibacterial Effect of Phage pB3074 in Combination with Antibiotics Targeting Cell Wall against Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Yang M; Liu M; Li Q; Wang P; Fan J; Jin J; Luo C
    Microbiol Spectr; 2023 Aug; 11(4):e0034123. PubMed ID: 37260382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.